Max Robotics — Global Service Robot Directory + US Certification

About

Anca Chipirliu is a leading figure in gynecologic oncology, with a focused expertise in minimally invasive surgical staging for gynecologic cancers. Her research primarily investigates the optimal surgical approach—extraperitoneal versus transperitoneal—for para-aortic lymphadenectomy in patients with early-stage ovarian, endometrial, and locally advanced cervical cancer. Chipirliu’s major contributions include demonstrating that the extraperitoneal route is associated with significantly fewer surgical complications, a finding solidified by her work on the STELLA-2 randomized trial. Her most cited paper (16 citations) compares these techniques in ovarian and endometrial cancer, while a subsequent post hoc analysis (15 citations) further validates the safety profile of robot-assisted extraperitoneal procedures. Additionally, her multicenter Spanish study (8 citations) explores the implications of extending lymphadenectomy to the left renal vein in cervical cancer. With a cumulative impact of nearly 40 citations on these key works, Chipirliu’s research directly informs clinical guidelines, helping surgeons reduce morbidity without compromising oncologic outcomes. Her rigorous, evidence-based approach makes her a vital contributor to advancing safer, more effective surgical standards in gynecologic oncology.